Vilin Bio Med Limited (NSE:VILINBIO)

Market Cap	403.16M
Revenue (ttm)	199.81M
Net Income (ttm)	2.51M
Shares Out	13.95M
EPS (ttm)	0.18
PE Ratio	160.76
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	32,000
Average Volume	16,800
Open	28.90
Previous Close	27.55
Day's Range	28.90 - 28.90
52-Week Range	16.50 - 32.50
Beta	-0.20
RSI	67.02
Earnings Date	Feb 11, 2026

About Vilin Bio Med

Vilin Bio Med Limited engages in the manufacture and trade of pharmaceutical products in India. It provides cardiovascular, musculo-skeletal, antibiotic, central nervous system, alimentary system, genito-urinary tract, respiratory system and anti-allergic, anti- diabetic, liquid orals, and miscellaneous drugs, as well as multi-vitamins, minerals, and amino acids supplements. The company offers its products in the form of oral liquids, dry syrups, sachets, external preparations, beta and non beta lactam tablets and capsules, and nutritional food...

• Industry: Pharmaceutical Preparations
• Founded: 2005
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VILINBIO

Financial Performance

In 2024, Vilin Bio Med's revenue was 148.10 million, a decrease of -6.30% compared to the previous year's 158.05 million. Earnings were 2.24 million, an increase of 37.62%.